|
SPIN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.999810E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.454500E-02 |
| Normal-vs-Stage2 |
9.873400E-01 |
| Normal-vs-Stage3 |
5.482200E-01 |
| Normal-vs-Stage4 |
7.088000E-01 |
| Stage1-vs-Stage2 |
3.180800E-01 |
| Stage1-vs-Stage3 |
5.697900E-02 |
| Stage1-vs-Stage4 |
8.774300E-02 |
| Stage2-vs-Stage3 |
6.680000E-01 |
| Stage2-vs-Stage4 |
7.680000E-01 |
| Stage3-vs-Stage4 |
9.703000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.255850E-01 |
| Normal-vs-AfricanAmerican |
3.160800E-01 |
| Normal-vs-Asian |
2.301000E-01 |
| Caucasian-vs-AfricanAmerican |
8.589200E-01 |
| Caucasian-vs-Asian |
7.556400E-01 |
| AfricanAmerican-vs-Asian |
7.297800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.227900E-02 |
| Normal-vs-Female |
2.611200E-01 |
| Male-vs-Female |
3.060900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.103600E-01 |
| Normal-vs-Extreme_Weight |
9.157400E-03 |
| Normal-vs-Obese |
8.056000E-01 |
| Normal-vs-Extreme_Obese |
1.201360E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.974170E-01 |
| Normal_Weight-vs-Obese |
3.065800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.342200E-01 |
| Extreme_Weight-vs-Obese |
1.404460E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.762800E-01 |
| Obese-vs-Extreme_Obese |
1.261560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.272000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.259600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.884100E-03 |
| Normal-vs-Age(81-100Yrs) |
8.381200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.048210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.020100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.561910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.019400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.841700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.829800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.706100E-02 |
| Normal-VS-Type2 PRCC |
1.317700E-02 |
| Normal-VS-KIRP CIMP |
2.996500E-02 |
| Normal-VS-Unclassified PRCC |
6.713800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.645040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.670380E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.631200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.130440E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.997800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.557800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.975700E-02 |
| Normal-vs-N1 |
1.123220E-01 |
| Normal-vs-N2 |
5.897800E-01 |
| N0-vs-N1 |
2.212100E-02 |
| N0-vs-N2 |
7.947400E-01 |
| N1-vs-N2 |
3.805400E-01 |
|
|
